tazarotene
tazarotene is listed in the FDA National Drug Code directory with 14 NDC codes, marketed under brand names including TAZORAC, Arazlo, TAZAROTENE. Available dosage forms: cream, lotion, gel, aerosol, foam.
Drug details
- Generic Name
- tazarotene
- Brand Names
- TAZORAC, Arazlo, TAZAROTENE, tazarotene, Tazorac, FABIOR
- Application Number
- NDA021184
- Sponsor
- Almirall, LLC
- NDC Codes
- 14
- Dosage Forms
- CREAM, LOTION, GEL, AEROSOL, FOAM
- Routes
- CUTANEOUS, TOPICAL
- Active Ingredients
- TAZAROTENE
Indications and Usage
1 INDICATIONS AND USAGE Trilitas™ gel, 0.1% is a retinoid indicated for the topical treatment of plaque psoriasis of up to 20% body surface area involvement. ( 1.1 ) Trilitas™ gel, 0.1% is indicated for the topical treatment of mild to moderate facial acne vulgaris. ( 1.2 ) Limitations of Use The safety of Trilitas™ gel use on more than 20% body surface area has not been established. ( 1.3 ) 1.1 Plaque Psoriasis Trilitas™ (tazarotene) gel, 0.1% is indicated for the topical treatment of patients with plaque psoriasis of up to 20% body surface area involvement. 1.2 Acne Vulgaris Trilitas™ (tazarotene) gel, 0.1% is also indicated for the topical treatment of patients with facial acne vulgaris of mild to moderate severity. The efficacy of Trilitas™ gel in the treatment of acne previously treated with other retinoids or resistant to oral antibiotics has not been established. 1.3 Limitations of Use The safety of Trilitas™ gel use on more than 20% body surface area has not been established in psoriasis or acne [see Warnings and Precautions (5.1) and Use in Specific Populations (8.1) ].